ARHGAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.99340544071447E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.07870379295605E-11 |
Normal-vs-Stage2 |
5.871500E-02 |
Normal-vs-Stage3 |
2.65910005126102E-09 |
Normal-vs-Stage4 |
1.63740000003187E-07 |
Stage1-vs-Stage2 |
2.405900E-04 |
Stage1-vs-Stage3 |
1.269010E-01 |
Stage1-vs-Stage4 |
7.202400E-01 |
Stage2-vs-Stage3 |
6.22759999999722E-05 |
Stage2-vs-Stage4 |
1.496720E-03 |
Stage3-vs-Stage4 |
3.185400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.31747995530441E-13 |
Normal-vs-AfricanAmerican |
4.42840000000055E-05 |
Normal-vs-Asian |
1.354390E-04 |
Caucasian-vs-AfricanAmerican |
9.860800E-01 |
Caucasian-vs-Asian |
5.075400E-01 |
AfricanAmerican-vs-Asian |
5.059200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.1977976650287E-11 |
Normal-vs-Female |
1.25629506797509E-11 |
Male-vs-Female |
2.534000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.355600E-04 |
Normal-vs-Age(41-60Yrs) |
1.88049575911009E-12 |
Normal-vs-Age(61-80Yrs) |
7.36840000126193E-09 |
Normal-vs-Age(81-100Yrs) |
3.202200E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.511400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.197200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.369200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.979500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.488600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.081200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.637400E-04 |
Normal-vs-Grade 2 |
5.81509995711826E-09 |
Normal-vs-Grade 3 |
1.20129994840568E-09 |
Normal-vs-Grade 4 |
9.76769998217719E-10 |
Grade 1-vs-Grade 2 |
2.663800E-02 |
Grade 1-vs-Grade 3 |
1.036840E-01 |
Grade 1-vs-Grade 4 |
8.564400E-01 |
Grade 2-vs-Grade 3 |
3.910000E-01 |
Grade 2-vs-Grade 4 |
5.637300E-04 |
Grade 3-vs-Grade 4 |
3.219800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.60709999999609E-06 |
Normal-vs-ccB subtype |
2.88657986402541E-14 |
ccA subtype-vs-ccB subtype |
3.5412999999096E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.79539955019936E-10 |
Normal-vs-N1 |
1.019400E-03 |
N0-vs-N1 |
8.870100E-02 |
|
|